Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease

Summary

This is a phase 3 study to evaluate the safety and efficacy of OmegaD softgels for the treatment of dry eye disease. A daily dose of 2 OmegaD softgels dosed orally BID will be compared to 2 placebo softgels dosed orally BID for 84 days. Approximately 164 subjects will be evaluated for their signs and symptoms of dry eye disease and for safety throughout the study.

Timeline

Start

2016-10

Primary completion

2017-02

Completion

2017-02

Drugs

Indications